NKTX Nkarta, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 10, 2026
$2,58
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,7052-Wochen-Tief
$3,7252-Wochen-Hoch
Marktkapitalisierung
$183M
P/E
-1.8
EPS
$-1.41
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$2–$4
Analystenbewertung
BUY
Kursziel
$11
P/E
-1.8
ROE
-31.1%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
NKTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.58
Marktkapitalisierung
$183M
P/E
-1.8
EPS
$-1.41
Umsatz
$0
ROE
-31.1%
52W-Spanne
$2–$4
NKTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02019-12-31 → 2025-12-31
EPS$-1.412021-12-31 → 2025-12-31
Freier Cashflow$-90M2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | NKTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.85-Jahres-Durchschnitt ≈-2.8 | ≈-2.8 | · | · | |
| P/B (K/B) | 0.65-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 3.6 | Unterbewertet | |
| Price / FCF (Kurs / FCF) | -2.05-Jahres-Durchschnitt ≈-3.1 | ≈-3.1 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -2.15-Jahres-Durchschnitt ≈-3.9 | ≈-3.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.65-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | NKTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -23.0%5-Jahres-Durchschnitt ≈-26.8% | ≈-26.8% | -31.6% | Spitzenklasse | |
| ROE | -31.1%5-Jahres-Durchschnitt ≈-32.2% | ≈-32.2% | -70.9% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | NKTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 8.05-Jahres-Durchschnitt ≈14.7 | ≈14.7 | 7.9 | Im Einklang | |
| Quick Ratio | 12.45-Jahres-Durchschnitt ≈14.3 | ≈14.3 | 6.3 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | NKTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.0 | ≈0.0 | 0.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-1.1%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.54 | $-0.38 | -40.8% |
| 31. März 2026 | Mai 12, 2026 | $-0.37 | $-0.38 | 2.6% |
| 31. Dezember 2025 | $-0.37 | $-0.32 | -14.1% | |
| 30. September 2025 | $-0.29 | $-0.32 | 9.3% | |
| 30. Juni 2025 | $-0.31 | $-0.36 | 14.4% | |
| 31. März 2025 | $-0.43 | $-0.45 | 4.2% | |
| 31. Dezember 2024 | $-0.35 | $-0.42 | 16.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | · | · | $0 | · | $115.0K | |
| R&D Expense | $90M | $97M | $97M | $91M | $63M | $36M | $17M | |
| SG&A Expense | $32M | $31M | $35M | $28M | $23M | $15M | $5M | |
| Operating Expenses | $122M | $128M | $132M | $119M | $86M | $52M | $22M | |
| Operating Income | $-122M | $-128M | $-132M | $-119M | $-86M | $-52M | $-22M | |
| Other Non-op | $2M | $87.0K | $42.0K | $-470.0K | $-16.0K | $-3.0K | $18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | $-21M | |
| EPS (Basic) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| EPS (Diluted) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · | |
| Shares (Basic) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| Shares (Diluted) | 73,991,197 | 67,865,323 | 49,014,300 | 43,631,722 | 32,856,883 | · | · | |
| EBITDA | $-113M | $-119M | $-126M | $-116M | $-85M | $-51M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $28M | $31M | $37M | $61M | $97M | $21M | |
| Short-term Investments | $237M | $239M | $217M | $315M | $177M | $218M | $16M | |
| Prepaid Expense | $6M | $6M | $5M | $9M | $8M | $4M | $474.0K | |
| Other Current Assets | $2M | $3M | $2M | $3M | $3M | $1M | $67.0K | |
| Current Assets | $283M | $273M | $253M | $361M | $246M | $319M | $37M | |
| PP&E (Net) | $67M | $75M | $79M | $62M | $13M | $9M | $3M | |
| PP&E (Gross) | $96M | $96M | $91M | $68M | $16M | $11M | $4M | |
| Accum. Depreciation | $29M | $21M | $12M | $6M | $3M | $1M | $645.0K | |
| Other Non-current Assets | $2M | $4M | $4M | $2M | $1M | $547.0K | $455.0K | |
| Total Assets | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Accounts Payable | $2M | $638.0K | $4M | $2M | $1M | $1M | $2M | |
| Accrued Liabilities | $13M | $12M | $14M | $16M | $9M | $6M | $3M | |
| Current Liabilities | $22M | $19M | $23M | $22M | $13M | $9M | $8M | |
| Capital Leases | $70M | $74M | $82M | $79M | $10M | $8M | $6M | |
| Other Non-current Liabilities | $87.0K | $87.0K | · | · | $18.0K | $82.0K | $134.0K | |
| Total Liabilities | $92M | $93M | $106M | $101M | $23M | $16M | $14M | |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $1.0K | |
| Retained Earnings | $-648M | $-544M | $-435M | $-318M | $-204M | $-118M | $-27M | |
| AOCI | $407.0K | $674.0K | $8.0K | $-679.0K | $-150.0K | $3.0K | $-2.0K | |
| Stockholders' Equity | $312M | $408M | $273M | $372M | $251M | $321M | $-25M | |
| Liabilities + Equity | $404M | $501M | $379M | $473M | $274M | $338M | $48M | |
| Shares Outstanding | 71,078,531 | 70,645,139 | 49,181,295 | 48,877,806 | 32,971,107 | 32,627,963 | 1,600,601 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $9M | $6M | $3M | $2M | $800.0K | $400.0K | |
| Stock-based Comp | $9M | $17M | $17M | $17M | $14M | $7M | $947.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-2M | $-17M | $8M | $37M | $2M | $40M | · | |
| Operating Cash Flow | $-89M | $-100M | $-86M | $-57M | $-68M | $-44M | $-18M | |
| CapEx | $1M | $4M | $28M | $47M | $5M | $8M | $2M | |
| Investing Cash Flow | $100M | $-130M | $79M | $-185M | $33M | $-210M | $-18M | |
| Financing Cash Flow | $141.0K | $226M | $691.0K | $219M | $1M | $330M | $50M | |
| Net Change in Cash | $12M | $-3M | $-6M | $-23M | $-34M | $76M | $13M | |
| Free Cash Flow | $-90M | $-104M | $-114M | $-104M | $-73M | $-51M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -23.0% | -24.7% | -27.6% | -30.5% | -28.1% | -47.3% | · | |
| ROE | -31.1% | -25.9% | -41.2% | -29.5% | -33.0% | -27.9% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 | 36.1 | · | |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 | 35.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.39 | $5.78 | $5.56 | $7.62 | $7.61 | $9.84 | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | · | · | · | |
| Cash Flow / Share | $-1.20 | $-1.47 | $-1.76 | $-1.31 | · | · | · | |
| Cash / Share | $0.56 | $0.39 | $0.63 | $0.77 | $1.84 | $2.96 | · | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | · | · | · | · | |
| EPS (TTM) | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | · | $0 | · | · | |
| Net Income TTM | $-104M | $-109M | $-118M | $-114M | $-86M | $-91M | · | |
| Market Cap | $131M | $176M | $325M | $293M | $506M | $2.01B | · | |
| P/E | -1.3 | -1.6 | -2.8 | -2.3 | -5.9 | · | · | |
| P/B | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Tangible Book | 0.4 | 0.4 | 1.2 | 0.8 | 2.0 | 6.2 | · | |
| P / Cash Flow | -1.5 | -1.8 | -3.8 | -5.1 | -7.5 | -46.1 | · | |
| P / FCF | -1.5 | -1.7 | -2.8 | -2.8 | -6.9 | -39.3 | · | |
| Earnings Yield | -76.2% | -64.3% | -36.4% | -43.6% | -17.1% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $29M | $25M | $25M | $20M | $21M | $24M | $23M | $25M | $23M | $25M | $23M | $22M | $25M | $26M | $27M | $23M | |
| SG&A Expense | $14M | $6M | $6M | $7M | $6M | $12M | $8M | $9M | $8M | $8M | $8M | $7M | $12M | $8M | $8M | $7M | |
| Operating Expenses | $43M | $31M | $31M | $27M | $27M | $37M | $31M | $34M | $31M | $33M | $31M | $29M | $37M | $34M | $35M | $30M | |
| Operating Income | $-43M | $-31M | $-31M | $-27M | $-27M | $-37M | $-31M | $-34M | $-31M | $-33M | $-31M | $-29M | $-37M | $-34M | $-35M | $-30M | |
| Other Non-op | $222.0K | $206.0K | $256.0K | $2M | $239.0K | $205.0K | $94.0K | $-3.0K | $-2.0K | $-2.0K | $-25.0K | $33.0K | $1.0K | $33.0K | $-489.0K | $17.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-40M | $-28M | $-27M | $-22M | $-23M | $-32M | $-26M | $-28M | $-25M | $-30M | $-28M | $-26M | $-33M | $-31M | $-33M | $-28M | |
| EPS (Basic) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| EPS (Diluted) | $-0.54 | $-0.37 | $-0.38 | $-0.29 | $-0.31 | $-0.43 | $-0.29 | $-0.39 | $-0.34 | $-0.58 | $-0.57 | $-0.52 | $-0.68 | $-0.63 | $-0.63 | $-0.58 | |
| Shares (Basic) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| Shares (Diluted) | 74,494,855 | 74,257,973 | · | 74,024,543 | 73,977,625 | 73,916,477 | · | 73,563,316 | 73,494,523 | 50,682,469 | · | 49,062,799 | 48,970,391 | 48,921,326 | · | 48,630,328 | |
| EBITDA | $-40M | $-29M | · | $-25M | $-25M | $-34M | · | $-31M | $-28M | $-30M | · | $-27M | $-36M | $-34M | · | $-30M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $27M | $40M | $60M | $53M | $53M | $28M | $57M | $120M | $250M | $31M | $38M | $29M | $54M | $37M | $40M | |
| Short-term Investments | $158M | $203M | $237M | $222M | $236M | $213M | $239M | $226M | $204M | $187M | $217M | $237M | $252M | $270M | $315M | $353M | |
| Prepaid Expense | $5M | $5M | $6M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $6M | $6M | $9M | $9M | $9M | |
| Other Current Assets | · | · | $2M | · | · | · | $3M | · | · | · | $2M | $2M | $3M | $3M | $3M | $3M | |
| Current Assets | $188M | $236M | $283M | $289M | $297M | $272M | $273M | $290M | $332M | $443M | $253M | $281M | $287M | $332M | $361M | $401M | |
| PP&E (Net) | $57M | $64M | $67M | $68M | $70M | $73M | $75M | $76M | $78M | $79M | $79M | $78M | $76M | $70M | $62M | $30M | |
| PP&E (Gross) | $93M | $96M | $96M | $96M | $96M | $96M | $96M | $95M | $94M | $92M | $91M | $87M | $84M | $76M | $68M | $35M | |
| Accum. Depreciation | $36M | $31M | $29M | $28M | $25M | $23M | $21M | $19M | $16M | $14M | $12M | $9M | $7M | $7M | $6M | $5M | |
| Other Non-current Assets | $1M | $2M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $2M | |
| Total Assets | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Accounts Payable | $4M | $2M | $2M | $1M | $2M | $1M | $638.0K | $2M | $4M | $3M | $4M | $4M | $3M | $5M | $2M | $9M | |
| Accrued Liabilities | $12M | $10M | $13M | $11M | $11M | $11M | $12M | $14M | $12M | $13M | $14M | $15M | $18M | $15M | $16M | $12M | |
| Current Liabilities | $24M | $18M | $22M | $19M | $19M | $19M | $19M | $22M | $21M | $22M | $23M | $26M | $27M | $26M | $22M | $26M | |
| Capital Leases | $66M | $68M | $70M | $70M | $72M | $73M | $74M | $79M | $80M | $81M | $82M | $83M | $84M | $86M | $79M | $78M | |
| Other Non-current Liabilities | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | $87.0K | · | · | · | · | · | · | · | · | $5.0K | |
| Total Liabilities | $90M | $86M | $92M | $89M | $91M | $92M | $93M | $101M | $101M | $103M | $106M | $109M | $111M | $112M | $101M | $105M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Retained Earnings | $-717M | $-676M | $-648M | $-621M | $-599M | $-576M | $-544M | $-518M | $-490M | $-465M | $-435M | $-408M | $-382M | $-349M | $-318M | $-285M | |
| AOCI | $-425.0K | $-130.0K | $407.0K | $536.0K | $362.0K | $652.0K | $674.0K | $2M | $-263.0K | $-127.0K | $8.0K | $-409.0K | $-601.0K | $-174.0K | $-679.0K | $-1M | |
| Stockholders' Equity | $248M | $286M | $312M | $338M | $358M | $379M | $408M | $431M | $453M | $474M | $273M | $297M | $318M | $347M | $372M | $399M | |
| Liabilities + Equity | $338M | $372M | $404M | $427M | $448M | $471M | $501M | $532M | $554M | $577M | $379M | $406M | $429M | $458M | $473M | $504M | |
| Shares Outstanding | · | · | 71,078,531 | · | · | · | 70,645,139 | · | · | · | 49,181,295 | · | · | · | 48,877,806 | · |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $800.0K | $700.0K | $700.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | |
| Restructuring | · | · | $-59.0K | $-26.0K | $-86.0K | $5M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-5M | · | · | · | $-3M | · | · | · | $-6M | · | · | · | $5M | · | · | |
| Operating Cash Flow | $-24M | $-28M | $-22M | $-19M | $-19M | $-30M | $-25M | $-25M | $-22M | $-29M | $-23M | $-20M | $-22M | $-21M | $-7M | $-15M | |
| CapEx | $183.0K | $413.0K | $560.0K | $-8.0K | $138.0K | $518.0K | $1M | $777.0K | $2M | $175.0K | $7M | $6M | $10M | $5M | $35M | $8M | |
| Investing Cash Flow | $21M | $16M | $1M | $25M | $19M | $54M | $-5M | $-39M | $-108M | $21M | $16M | $29M | $-3M | $37M | $5M | $-79M | |
| Financing Cash Flow | $676.0K | $6.0K | $64.0K | $0 | $77.0K | $0 | $184.0K | $2.0K | $-368.0K | $226M | $295.0K | $0 | $395.0K | $1.0K | $424.0K | $3M | |
| Net Change in Cash | $-2M | $-12M | $-20M | $7M | $816.0K | $25M | $-29M | $-63M | $-130M | $219M | $-7M | $9M | $-25M | $16M | $-2M | $-91M | |
| Free Cash Flow | · | $-29M | · | · | · | $-30M | · | · | · | $-29M | · | · | · | $-26M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.3% | -6.6% | · | -4.5% | -4.6% | -6.1% | · | -6.0% | -5.1% | -5.7% | · | -5.6% | -7.1% | -8.1% | · | -7.1% | |
| ROE | -13.3% | -8.4% | · | -5.7% | -5.7% | -7.5% | · | -7.8% | -6.5% | -7.2% | · | -7.4% | -9.0% | -10.7% | · | -8.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 13.0 | · | 15.2 | 15.7 | 14.5 | · | 12.9 | 15.9 | 20.0 | · | 11.0 | 10.8 | 12.8 | · | 15.2 | |
| Quick Ratio | 7.8 | 12.7 | · | 14.9 | 15.3 | 14.2 | · | 12.6 | 15.6 | 19.7 | · | 10.7 | 10.5 | 12.4 | · | 14.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow / Share | · | $-0.38 | · | · | · | $-0.40 | · | · | · | $-0.56 | · | · | · | $-0.42 | · | · | |
| EPS (TTM) | $-1.58 | $-1.35 | · | $-1.32 | $-1.42 | $-1.45 | · | $-1.88 | $-2.01 | $-2.35 | · | $-2.46 | $-2.52 | $-2.45 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-117M | $-100M | · | $-103M | $-109M | $-111M | · | $-111M | $-108M | $-116M | · | $-122M | $-125M | $-119M | · | · | |
| P/E | -1.8 | -1.6 | · | -1.6 | -1.2 | -1.3 | · | -2.4 | -2.9 | -4.6 | · | -0.6 | -0.9 | -1.4 | · | · | |
| Earnings Yield | -55.8% | -64.0% | · | -63.8% | -85.5% | -78.8% | · | -41.6% | -34.0% | -21.7% | · | -177.0% | -115.1% | -69.0% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $0 | $0 | · | · | $0 |
| Nettoergebnis | $-104M | $-109M | $-118M | $-114M | $-86M |
| Verwässerte EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 | $-2.62 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.7 | 14.4 | 10.8 | 16.4 | 19.0 |
| Quick Ratio | 12.4 | 14.1 | 10.6 | 16.0 | 18.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-90M | $-104M | $-114M | $-104M | $-73M |
Institutionelle Eigentümer (13F) 146 Einreicher · $167.8M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
146
Gehaltener Wert
$167.8M
Neue Positionen
27
Geschlossene Positionen
13
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 27 (+5 vs. Vorquartal) | 13 (+4 vs. Vorquartal) | 51 (+4 vs. Vorquartal) | 37 (+6 vs. Vorquartal) | +230K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $30.578.515 | 10.805.129 | 18,23% | Aktien |
| BlackRock, Inc. | $17.829.600 | 6.300.212 | 10,63% | Aktien |
| NEA Management Company, LLC | $10.099.650 | 3.568.781 | 6,02% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $9.926.695 | 3.507.666 | 5,92% | Aktien |
| SR One Capital Management, LP | $9.433.332 | 3.333.333 | 5,62% | Aktien |
| GSK plc | $8.916.572 | 3.150.732 | 5,32% | Aktien |
| Monaco Asset Management SAM | $6.716.722 | 2.373.400 | 4,00% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.300.754 | 2.226.415 | 3,76% | Aktien |
| CITADEL ADVISORS LLC | $6.154.528 | 2.174.745 | 3,67% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.301.419 | 1.873.293 | 3,16% | Aktien |
| VANGUARD GROUP INC | $4.805.134 | 2.597.370 | 2,86% | Aktien |
| STATE STREET CORP | $3.639.688 | 1.286.109 | 2,17% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.638.743 | 1.285.507 | 2,17% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $3.332.755 | 1.177.652 | 1,99% | Aktien |
| WASATCH ADVISORS LP | $3.329.257 | 1.577.847 | 1,98% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.983.530 | 1.054.251 | 1,78% | Aktien |
| AWM Investment Company, Inc. | $2.563.980 | 906.000 | 1,53% | Aktien |
| Blackstone Inc. | $2.114.135 | 747.044 | 1,26% | Aktien |
| MARSHALL WACE, LLP | $1.904.620 | 673.010 | 1,14% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.650.595 | 583.249 | 0,98% | Aktien |
| JPMORGAN CHASE & CO | $1.604.493 | 562.980 | 0,96% | Aktien |
| Peapod Lane Capital LLC | $1.556.282 | 549.923 | 0,93% | Aktien |
| Alyeska Investment Group, L.P. | $1.372.097 | 484.840 | 0,82% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.367.703 | 483.211 | 0,82% | Aktien |
| Nuveen, LLC | $1.328.840 | 469.555 | 0,79% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.228.169 | 433.982 | 0,73% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.197.320 | 647.200 | 0,71% | Aktien |
| NORTHERN TRUST CORP | $1.051.133 | 371.425 | 0,63% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $985.366 | 348.186 | 0,59% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $915.955 | 323.659 | 0,55% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $854.422 | 301.916 | 0,51% | Aktien |
| XTX Topco Ltd | $820.658 | 289.985 | 0,49% | Aktien |
| MORGAN STANLEY | $746.479 | 263.773 | 0,44% | Aktien |
| Invesco Ltd. | $586.701 | 207.315 | 0,35% | Aktien |
| IEQ CAPITAL, LLC | $501.017 | 177.038 | 0,30% | Aktien |
| D. E. Shaw & Co., Inc. | $459.900 | 162.509 | 0,27% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $370.659 | 130.975 | 0,22% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $367.900 | 130.000 | 0,22% | Aktien |
| FMR LLC | $367.736 | 129.942 | 0,22% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $357.539 | 126.339 | 0,21% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $347.524 | 122.800 | 0,21% | Aktien |
| BARCLAYS PLC | $344.042 | 121.570 | 0,21% | Aktien |
| Qube Research & Technologies Ltd | $341.889 | 120.809 | 0,20% | Aktien |
| MACKENZIE FINANCIAL CORP | $325.985 | 115.189 | 0,19% | Aktien |
| Bank of New York Mellon Corp | $324.978 | 114.833 | 0,19% | Aktien |
| JANE STREET GROUP, LLC | $315.899 | 111.625 | 0,19% | Aktien |
| Point72 Asset Management, L.P. | $302.261 | 106.806 | 0,18% | Aktien |
| Man Group plc | $283.133 | 100.047 | 0,17% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $268.428 | 94.851 | 0,16% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $233.922 | 82.658 | 0,14% | Aktien |
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×4 Einreichungen | 19. Mai 2026 | 4,90% | Änderung | Passive Anlage | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Srinivas Akkaraju ×4 Einreichungen | 24. November 2025 | 4,90% | Änderung | · | SEC |
| LSP 6 Management B.V., LSP 6 Holding C.V., LSP 6 NK Holding B.V ×3 Einreichungen | 12. Februar 2025 | 4,00% | Änderung | · | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×3 Einreichungen | 29. März 2024 | · | Erste Einreichung | · | SEC |
| Novo Holdings A/S ×4 Einreichungen | 3. Juni 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 10 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul J Hastings | Chief Executive Officer | 18. Juni 2026 S | 390.247 | 0 | 2 | $-58.728 |
| Matthew Plunkett | Chief Financial Officer | 9. Juli 2020 A | · | 0 | 0 | $0 |
| Nadir Mahmood | President | 15. Januar 2026 S | 167.727 | 0 | 1 | $-11.693 |
| Shawn Marshall Rose | Chief Medical Officer, Head of Research & Development | 6. Januar 2026 A | 70.000 | 0 | 0 | $0 |
| Alyssa Levin | Chief Financial and Business Officer | 15. Januar 2025 S | 102.662 | 0 | 0 | $0 |
| David Shook | Chief Medical Officer, Head of Research & Development | 15. Januar 2025 S | 190.955 | 0 | 0 | $0 |
| Ralph Brandenberger | Chief Technical Officer | 15. Januar 2025 S | 124.796 | 0 | 0 | $0 |
| Alicia J. Hager | Chief Legal Officer | 15. Januar 2025 S | 146.735 | 0 | 0 | $0 |
| James Trager | Chief Scientific Officer | 18. Juni 2024 S | 150.959 | 0 | 0 | $0 |
| Kanya Rajangam | Chief Medical Officer | 14. Januar 2022 A | 12.800 | 0 | 0 | $0 |
| George Vratsanos | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Zachary Scheiner | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Angela Thedinga | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Ali Behbahani | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Michael Dybbs | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Simeon George | Direktor | 10. Juni 2026 A | 451.659 | 0 | 0 | $0 |
| Leone D Patterson | Direktor | 10. Juni 2026 A | · | 0 | 0 | $0 |
| Fouad Oscar Azzam | Direktor | 7. Juni 2023 A | · | 0 | 0 | $0 |
| Tiba Aynechi | Direktor | 8. Juni 2022 A | · | 0 | 0 | $0 |
| Laura Shawver | Direktor | 8. Juni 2022 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| Peter W. Sonsini | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| Novo Holdings A/S | 10%-Eigentümer | 14. Juli 2020 C | 2.793.865 | 0 | 0 | $0 |
| Forest Baskett | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| Scott D. Sandell | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| Joshua Makower | 10%-Eigentümer | 14. Juli 2020 C | 2.902.115 | 0 | 0 | $0 |
| GSK plc | · | 14. Juli 2020 A | 3.150.732 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 17 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 80.111 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 149.326 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 38.962 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 103.233 SH | 30. September 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 1.123.160 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,00% | 21.336 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 145.492 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 3.413 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.031 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17.065 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 8.973 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 599.527 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.567.021 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 259.168 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.786 SH | 19. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 6.442 NS | 31. Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 452.090 SH | 11. September 2026 | Täglich |
NKTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$10.50
+307,8%
4 30,8%
Starker Kauf
8 61,5%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-10-03Mittelwert-Ziel $10.83 +320,7%
← Unter allen Zielen
Aktueller Preis $2.58
Tief$9.00
Mittelwert$10.83
Hoch$14.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | · |
| ALXO | $61M | -0.6 | · | · | -225.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 10, 2026